vs
AXCELIS TECHNOLOGIES INC（ACLS）与Oncology Institute, Inc.（TOI）财务数据对比。点击上方公司名可切换其他公司
AXCELIS TECHNOLOGIES INC的季度营收约是Oncology Institute, Inc.的1.7倍（$238.3M vs $142.0M），AXCELIS TECHNOLOGIES INC净利率更高（14.4% vs -5.3%，领先19.7%），Oncology Institute, Inc.同比增速更快（41.6% vs -5.6%），Oncology Institute, Inc.自由现金流更多（$2.2M vs $-8.9M），过去两年Oncology Institute, Inc.的营收复合增速更高（22.5% vs -2.8%）
Axcelis Technologies是一家美国半导体设备供应商，1995年成立，总部位于美国马萨诸塞州贝弗利。公司面向全球半导体制造行业，从事半导体生产核心设备的设计、制造及服务，主营产品包括高中电流、高能离子注入系统以及半导体芯片制造用固化系统。
肿瘤研究所股份有限公司是一家专注于肿瘤诊疗领域的专业医疗企业，提供循证抗癌治疗方案、临床试验参与通道及配套支持护理服务，主要面向美国境内各类癌症患者，协同医疗从业者优化诊疗效果。
ACLS vs TOI — 直观对比
营收规模更大
ACLS
是对方的1.7倍
$142.0M
营收增速更快
TOI
高出47.2%
-5.6%
净利率更高
ACLS
高出19.7%
-5.3%
自由现金流更多
TOI
多$11.1M
$-8.9M
两年增速更快
TOI
近两年复合增速
-2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $238.3M | $142.0M |
| 净利润 | $34.3M | $-7.5M |
| 毛利率 | 47.0% | — |
| 营业利润率 | 15.2% | -4.9% |
| 净利率 | 14.4% | -5.3% |
| 营收同比 | -5.6% | 41.6% |
| 净利润同比 | -31.3% | 43.0% |
| 每股收益（稀释后） | $1.11 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLSTOI
| Q4 25 | $238.3M | $142.0M | ||
| Q3 25 | $213.6M | $136.6M | ||
| Q2 25 | $194.5M | $119.8M | ||
| Q1 25 | $192.6M | $104.4M | ||
| Q4 24 | $252.4M | $100.3M | ||
| Q3 24 | $256.6M | $99.9M | ||
| Q2 24 | $256.5M | $98.6M | ||
| Q1 24 | $252.4M | $94.7M |
净利润ACLSTOI
| Q4 25 | $34.3M | $-7.5M | ||
| Q3 25 | $26.0M | $-16.5M | ||
| Q2 25 | $31.4M | $-17.0M | ||
| Q1 25 | $28.6M | $-19.6M | ||
| Q4 24 | $50.0M | $-13.2M | ||
| Q3 24 | $48.6M | $-16.1M | ||
| Q2 24 | $50.9M | $-15.5M | ||
| Q1 24 | $51.6M | $-19.9M |
毛利率ACLSTOI
| Q4 25 | 47.0% | — | ||
| Q3 25 | 41.6% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 46.1% | — | ||
| Q4 24 | 46.0% | — | ||
| Q3 24 | 42.9% | — | ||
| Q2 24 | 43.8% | — | ||
| Q1 24 | 46.0% | — |
营业利润率ACLSTOI
| Q4 25 | 15.2% | -4.9% | ||
| Q3 25 | 11.7% | -5.9% | ||
| Q2 25 | 14.9% | -9.4% | ||
| Q1 25 | 15.1% | -9.5% | ||
| Q4 24 | 21.6% | -11.9% | ||
| Q3 24 | 18.3% | -13.9% | ||
| Q2 24 | 20.6% | -16.6% | ||
| Q1 24 | 22.4% | -19.0% |
净利率ACLSTOI
| Q4 25 | 14.4% | -5.3% | ||
| Q3 25 | 12.2% | -12.1% | ||
| Q2 25 | 16.1% | -14.2% | ||
| Q1 25 | 14.8% | -18.8% | ||
| Q4 24 | 19.8% | -13.1% | ||
| Q3 24 | 18.9% | -16.1% | ||
| Q2 24 | 19.8% | -15.7% | ||
| Q1 24 | 20.4% | -21.0% |
每股收益（稀释后）ACLSTOI
| Q4 25 | $1.11 | $-0.04 | ||
| Q3 25 | $0.83 | $-0.14 | ||
| Q2 25 | $0.98 | $-0.15 | ||
| Q1 25 | $0.88 | $-0.21 | ||
| Q4 24 | $1.54 | $-0.14 | ||
| Q3 24 | $1.49 | $-0.18 | ||
| Q2 24 | $1.55 | $-0.17 | ||
| Q1 24 | $1.57 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $374.3M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.0B | $-15.7M |
| 总资产 | $1.4B | $164.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACLSTOI
| Q4 25 | $374.3M | — | ||
| Q3 25 | $449.6M | — | ||
| Q2 25 | $549.8M | — | ||
| Q1 25 | $587.1M | — | ||
| Q4 24 | $571.3M | — | ||
| Q3 24 | $579.4M | — | ||
| Q2 24 | $548.3M | $9.9M | ||
| Q1 24 | $530.2M | $29.8M |
股东权益ACLSTOI
| Q4 25 | $1.0B | $-15.7M | ||
| Q3 25 | $1.0B | $-12.3M | ||
| Q2 25 | $1.0B | $-9.0M | ||
| Q1 25 | $1.0B | $5.1M | ||
| Q4 24 | $1.0B | $3.6M | ||
| Q3 24 | $975.6M | $15.5M | ||
| Q2 24 | $934.9M | $29.2M | ||
| Q1 24 | $901.7M | $41.3M |
总资产ACLSTOI
| Q4 25 | $1.4B | $164.7M | ||
| Q3 25 | $1.4B | $163.6M | ||
| Q2 25 | $1.3B | $159.8M | ||
| Q1 25 | $1.3B | $164.0M | ||
| Q4 24 | $1.3B | $172.7M | ||
| Q3 24 | $1.3B | $179.2M | ||
| Q2 24 | $1.3B | $179.6M | ||
| Q1 24 | $1.3B | $204.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $2.2M |
| 自由现金流率自由现金流/营收 | -3.7% | 1.5% |
| 资本支出强度资本支出/营收 | 1.0% | 0.7% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | $107.0M | $-27.8M |
8季度趋势，按日历期对齐
经营现金流ACLSTOI
| Q4 25 | $-6.6M | $3.2M | ||
| Q3 25 | $45.4M | $-12.6M | ||
| Q2 25 | $39.7M | $-10.2M | ||
| Q1 25 | $39.8M | $-5.0M | ||
| Q4 24 | $12.8M | $4.2M | ||
| Q3 24 | $45.7M | $819.0K | ||
| Q2 24 | $40.1M | $-15.7M | ||
| Q1 24 | $42.2M | $-15.9M |
自由现金流ACLSTOI
| Q4 25 | $-8.9M | $2.2M | ||
| Q3 25 | $43.3M | $-13.2M | ||
| Q2 25 | $37.7M | $-11.4M | ||
| Q1 25 | $34.8M | $-5.3M | ||
| Q4 24 | $8.1M | $2.4M | ||
| Q3 24 | $41.8M | $417.0K | ||
| Q2 24 | $38.1M | $-17.5M | ||
| Q1 24 | $40.6M | $-16.5M |
自由现金流率ACLSTOI
| Q4 25 | -3.7% | 1.5% | ||
| Q3 25 | 20.3% | -9.7% | ||
| Q2 25 | 19.4% | -9.5% | ||
| Q1 25 | 18.1% | -5.1% | ||
| Q4 24 | 3.2% | 2.4% | ||
| Q3 24 | 16.3% | 0.4% | ||
| Q2 24 | 14.8% | -17.7% | ||
| Q1 24 | 16.1% | -17.4% |
资本支出强度ACLSTOI
| Q4 25 | 1.0% | 0.7% | ||
| Q3 25 | 0.9% | 0.4% | ||
| Q2 25 | 1.0% | 1.0% | ||
| Q1 25 | 2.6% | 0.3% | ||
| Q4 24 | 1.8% | 1.8% | ||
| Q3 24 | 1.5% | 0.4% | ||
| Q2 24 | 0.8% | 1.9% | ||
| Q1 24 | 0.6% | 0.6% |
现金转化率ACLSTOI
| Q4 25 | -0.19× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.94× | — | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACLS
| Products | $224.6M | 94% |
| Services | $13.7M | 6% |
TOI
| Other | $82.1M | 58% |
| Fee For Service | $36.3M | 26% |
| Capitated Revenue | $23.6M | 17% |
